C0005953||Bone Marrow
C1257975||Mesenchymal Stem Cells
C2350332||Exosomes
C0007620||Survival
C0035316||Retinal Ganglion Cells
C1101610||miRNA
C0035316||retinal ganglion cells
C0035316||retinal ganglion cells
C0004461||axons
C0456909||blindness
C0015408||traumatic
C3887709||optic neuropathy
C0154777||degenerative
C0017601||glaucoma
C0015397||eye diseases
C1513916||no
C0087111||clinical therapies
C1257975||mesenchymal stem cells
C1257975||mesenchymal stem cells
C0007613||axogenic effects
C0035316||retinal ganglion cells
C1257975||mesenchymal stem cells
C2350332||exosomes
C0596901||membrane
C1622418||vesicles
C0033684||proteins
C0035696||mRNA
C1101610||miRNA
C0007634||cells
C2603343||study
C2350332||exosomes
C0005953||bone marrow
C1257975||mesenchymal stem cells
C1257975||bone marrow -derived MSC
C0034693||rat
C0012644||optic nerve crush (ONC) model
C0430400||primary retinal cultures
C1257975||bone marrow -derived MSC
C2350332||exosomes
C0007613||neuritogenic effects
C0012644||optic nerve crush
C0920367||optical coherence tomography
C0013867||electroretinography
C0021044||immunohistochemistry
C1257975||bone marrow -derived MSC
C2350332||exosomes
C0007620||survival
C0035316||retinal ganglion cells
C0004461||axons
C0035316||retinal ganglion cells
C0035316||retinal ganglion cells
C2350332||Exosomes
C0229211||inner retinal layers
C1101610||miRNA
C1527144||therapeutic effects
C2350332||exosomes
C1257975||bone marrow -derived MSC
C2350567||knockdown
C1414333||Argonaute-2
C1101610||miRNA
C2603343||study
C1257975||bone marrow -derived MSC
C2350332||exosomes
C0087111||cell-free therapy
C0015408||traumatic
C0154777||degenerative ocular disease